CHRONOTHERAPY OF 6-MERCAPTOPURINE (6-MP) METABOLITES IN INFLAMMATORY BOWEL DISEASE: A CROSSOVER TRIAL

被引：0
|
作者：
Swanson, Garth
Biglin, Mary
Chouhan, Vijit
Raff, Hannah
Sanzo, Gabreilla
Bishehsari, Faraz
Keshavarzian, Ali
机构：
来源：
GASTROENTEROLOGY | 2020年 / 158卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1888
引用
收藏
页码：S466 / S467
页数：2
相关论文
共 50 条
  • [21] Pharmacokinetics of 6-mercaptopurine in patients with inflammatory bowel disease
    Derijks, LJJ
    Gilissen, LPL
    Engels, LGJB
    Bos, LP
    Bus, PJ
    Lohman, JJHM
    Hooymans, PM
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 (04) : 466 - 466
  • [22] AZATHIOPRINE, 6-MERCAPTOPURINE, AND INFLAMMATORY BOWEL-DISEASE
    BEAUGERIE, L
    GENDRE, JP
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1990, 14 (03): : 230 - 240
  • [23] Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine
    Su, CY
    Lichtenstein, GR
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2004, 33 (02) : 209 - +
  • [24] HOW IMPORTANT ARE THE VARIABLE PHARMACOKINETICS OF 6-MERCAPTOPURINE (6-MP) IN THE THERAPY OF ALL
    LILLEYMAN, JS
    LENNARD, L
    MEDICAL AND PEDIATRIC ONCOLOGY, 1988, 16 (06): : 385 - 385
  • [25] Hepatotoxicity of 6-mercaptopurine (6-MP) and azathioprine (AZA) in adult IBD patients
    Shaye, Omid A.
    Yadegari, Michael
    Abreu, Maria T.
    Poordad, Fred
    Simon, Karen
    Martin, Paul
    Papadakis, Konstantinos A.
    Ippoliti, Andrew
    Vasiliauskas, Eric
    Tran, Tram T.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (11): : 2488 - 2494
  • [26] Serial 6-mercaptopurine (6-MP) metabolite measurements in combination with dose escalation unmasks an important biochemical explanation for "6-MP resistance".
    Dubinsky, MC
    Hassard, PV
    Kam, LY
    Abreu, MT
    Seidman, EG
    Targan, SR
    Vasiliauskas, EA
    GASTROENTEROLOGY, 2000, 118 (04) : A890 - A890
  • [27] Treatment of Crohn's disease (CD) with 6-mercaptopurine (6-MP) in patients intolerant to azathioprine (AZA).
    Lemann, M
    Bouhnik, Y
    Corguille, MKL
    Bonnet, J
    Coffin, B
    Marteau, P
    Bitoun, A
    Messing, B
    Jian, R
    Matuchansky, C
    Modigliani, R
    Rambaud, JC
    GASTROENTEROLOGY, 1997, 112 (04) : A1025 - A1025
  • [28] 6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease
    Dubinsky, MC
    Yang, HY
    Hassard, PV
    Seidman, EG
    Kam, LY
    Abreu, MT
    Targan, SR
    Vasiliauskas, EA
    GASTROENTEROLOGY, 2002, 122 (04) : 904 - 915
  • [29] EFFECTS OF 6-MERCAPTOPURINE (6-MP) AND AZATHIOPRINE ON HUMAN BONE MARROW IN-VITRO
    BOLL, I
    KLIMAS, J
    WILLIGERODT, B
    ARZNEIMITTEL-FORSCHUNG, 1971, 21 (04): : 502 - +
  • [30] EFFECT OF 6-MERCAPTOPURINE (6-MP) AND METHOTREXATE (MTX) ON PASSIVE DELAYED HYPERSENSITIVITY REACTIONS
    BOREL, Y
    FAUCONNET, M
    MIESCHER, PA
    INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1968, 33 (06): : 583 - +
12345